Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Onyx Pharmaceuticals, Inc.    ONXX   US6833991093

 SummaryQuotesChart AnalysisNewsCalendar 
Company
Sector
Calendar
05/06Earnings Release
More about the company
Chart ONYX PHARMACEUTICALS, INC.
Duration : Period :
Onyx Pharmaceuticals, Inc. Technical Analysis Chart | ONXX | US6833991093 | 4-Traders
Full-screen chart
Latest news on ONYX PHARMACEUTICALS, INC.
03/11 ONYX PHARMACEUTICALS, INC. : Bayer and Onyx Report Phase 3 Study Results of NEXA..
03/11DJBAYER : Phase III Trial of Sorafenib for Liver Cancer Did Not Meet Primary Endpo..
2013 ONYX PHARMACEUTICALS, INC. : The International Myeloma Foundation Announces Part..
2013 ONYX PHARMACEUTICALS, INC. : U.S. FDA Approves NEXAVAR® (sorafenib) for the Trea..
2013 ONYX PHARMACEUTICALS, INC. : Amgen and Onyx Pharmaceuticals Announce Upcoming Da..
2013 ONYX PHARMACEUTICALS, INC. : Amgen Successfully Completes Onyx Pharmaceuticals T..
2013 ONYX PHARMACEUTICALS, INC. : Amgen and Onyx Pharmaceuticals Announce Early Termi..
2013 ONYX PHARMACEUTICALS, INC. : Onyx Pharmaceuticals Announces Data Presentations a..
2013 ONYX PHARMACEUTICALS, INC. : Bayer’s Stivarga® (regorafenib) Tablets Approved in..
2013 ONYX PHARMACEUTICALS, INC. : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces ..
2013 ONYX PHARMACEUTICALS, INC. : Faruqi & Faruqi, LLP, Partner Juan E. Monteverde La..
2013 ONYX PHARMACEUTICALS, INC. : Rigrodsky & Long, P.A. Announces Investigation Of O..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Dynamic quotes  
ON
| OFF